不安腿综合征 影响 睡眠 de novo 帕金森病 患者 患者
Seong-Min Choi1,2, Bang-Hoon Cho3, Soo H Cho4
1Department of Neurology, Chonnam National University Medical School and Hospital, Gwangju, South Korea.
Neurology India
|August 31, 2024
概括
不安腿综合征 (RLS) 在帕金森病 (PD) 患者中很常见,严重影响睡眠质量和白天功能. 管理RLS对于改善PD个体经历的非运动症状至关重要.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 运动障碍 运动障碍
背景情况:
- 不安腿综合征 (RLS) 经常影响帕金森病 (PD) 患者.
- 在患有PD的个体中,RLS可以加剧运动和非运动症状.
研究的目的:
- 调查RLS在新发帕金森病患者中影响的临床因素.
- 了解RLS对早期PD非运动症状的具体影响.
主要方法:
- 包括369名新的PD患者.
- 通过面对面的采访来评估RLS.
- 使用标准化尺度对运动和非运动症状的评估.
主要成果:
- 在新的PD患者中,RLS患病率为12.2% (45/369).
- 患有RLS的PD患者显示匹兹堡睡眠质量指数 (PSQI) 得分明显更高,特别是在白天功能障碍和睡眠障碍方面.
- 非运动症状尺度的睡眠/疲劳域在患有RLS的PD患者中也显着更高.
结论:
- 在新的PD患者中,RLS的患病率超过了一般人群中的患病率.
- 睡眠障碍是RLS在PD中影响的主要非运动症状.
- 有效的RLS管理对于解决PD患者的睡眠障碍至关重要.
相关概念视频
Restless Leg Syndrome and Night Terrors
157
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
157
REM Sleep Behavior Disorder
162
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
162
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Narcolepsy
95
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
95
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K


